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Effectiveness of a community program for
older adults with type 2 diabetes and
multimorbidity: a pragmatic randomized
controlled trial
John J. Miklavcic1,2,3 , Kimberly D. Fraser3, Jenny Ploeg4* , Maureen Markle-Reid5,6 , Kathryn Fisher7 ,
Amiram Gafni8 , Lauren E. Griffith9 , Sandra Hirst10, Cheryl A. Sadowski11 , Lehana Thabane12,
Jean A. C. Triscott13,14 and Ross Upshur15
Abstract
Background: Type II diabetes mellitus (T2DM) affects upwards of 25% of Canadian older adults and is associated
with high comorbidity and burden. Studies show that lifestyle factors and self-management are associated with
improved health outcomes, but many studies lack rigour or exclude older adults, particularly those with
multimorbidity. More evidence is needed on the effectiveness of community-based self-management programs in
older adults with T2DM and multimorbidity. The study purpose is to evaluate the effect of a community-based
intervention versus usual care on physical functioning, mental health, depressive symptoms, anxiety, self-efficacy,
self-management, and healthcare costs in older adults with T2DM and 2 or more comorbidities.
Methods: Community-living older adults with T2DM and two or more chronic conditions were recruited from
three Primary Care Networks (PCNs) in Alberta, Canada. Participants were randomly allocated to the intervention or
control group in this pragmatic randomized controlled trial comparing the intervention to usual care. The
intervention involved up to three in-home visits, a monthly group wellness program, monthly case conferencing,
and care coordination. The primary outcome was physical functioning. Secondary outcomes included mental
functioning, anxiety, depressive symptoms, self-efficacy, self-management, and the cost of healthcare service use.
Intention-to-treat analysis was performed using ANCOVA modeling.
Results: Of 132 enrolled participants (70-Intervention, 62-Control), 42% were 75 years or older, 55% were female,
and over 75% had at least six chronic conditions (in addition to T2DM). No significant group differences were seen
for the baseline to six-month change in physical functioning (mean difference: -0.74; 95% CI: − 3.22, 1.74; p-value:
0.56), mental functioning (mean difference: 1.24; 95% CI: − 1.12, 3.60; p-value: 0.30), or other secondary outcomes..
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Conclusion: No significant group differences were seen for the primary outcome, physical functioning (PCS).
Program implementation, baseline differences between study arms and chronic disease management services that
are part of usual care may have contributed to the modest study results. Fruitful areas for future research include
capturing clinical outcome measures and exploring the impact of varying the type and intensity of key intervention
components such as exercise and diet.
Trial registration: NCT02158741 Date of registration: June 9, 2014.
Keywords: Type 2 diabetes mellitus, Comorbidity, Older adults, Self-management, Aging, Community-based
program
Background
The World Health Organization reports that the number
of people with diabetes worldwide was 422 million in
2014 [1]. Approximately 2.3 million Canadians aged 12
years and older reported a diagnosis of diabetes in 2017
[2]. The prevalence of diabetes continues to grow, with
the 10 year-risk (2012 to 2022) of developing diabetes in
Canadians aged 20 years or older estimated at 9.98%
(2.16 million new cases) and associated total costs of dia-
betes (excluding informal care) estimated at $15.36 bil-
lion dollars [3]. It is estimated that in 2018, 17.9% of
Canadians aged 65 years and over (1,094,600) had dia-
betes [4]. Type 2 diabetes mellitus (T2DM) constitutes
approximately 90% of all diabetes cases [5] and the man-
agement of T2DM is particularly challenging in older
adults with multimorbidity. A study in Ontario showed
that more than 90% of older adults with diabetes (> 65
years) have at least one comorbid condition and almost
50% have 5 or more comorbid conditions [6]. The num-
ber of physician visits, hospitalizations, and associated
healthcare costs increases in older adults in proportion
to the number of comorbid conditions [6]. There is a
need for novel and effective strategies to improve man-
agement of T2DM and MCC within the context of lim-
ited healthcare services and resources.
Self-management interventions similar to those used
in diabetes prevention programs such as the Finnish
Diabetes Prevention Study (FDPS) [7, 8] and the U.S.
Diabetes Prevention Program (DPP) [9, 10] are recom-
mended for people with T2DM. These programs are
multi-faceted and include components such as motiv-
ational interviewing, problem solving therapy, patient
education and lifestyle modifications. The lifestyle modi-
fications targeted by these programs are appropriate for
both diabetes prevention and treatment and have dem-
onstrated effectiveness and long-term sustainability. A
recent integrative review of 70 studies summarizing the
results of testing 8 types of interventions for T2DM
across 17 countries reported mixed findings, but noted
that many studies supported small to modest improve-
ments in physiologic, behavioural, and psychological
outcomes [11]. This review also noted that self-
management programs typically involve a range of pro-
fessionals and non-professionals working together to
provide team-based care. The literature has referred to
these programs as integrated care interventions, with the
associated systematic reviews reporting mixed results
similar to those described above [12].
There is increasing interest in community-based pro-
grams, particularly those targeting chronic disease man-
agement, because of the resource intensity and resulting
high costs of clinic-based programs like the DPP and
FDPS, yet the current evidence in support of these pro-
grams is weak. A systematic review of studies evaluating
the translation of the DPP into primary care, community
and work settings reported variable rates of adoption,
implementation and sustainability, and recommended
better integration of the programs within existing
organizational infrastructures (e.g., YMCA) to address
these issues [13]. A 2016 Cochrane review of
community-based interventions for multimorbidity
(many including T2DM) reported no improvements in
self-management behaviours, healthcare service use or
clinical outcomes and only a small benefit to mental
health for programs that targeted specific risk factors or
functional limitations [14]. Reliability has been a key
concern with existing studies of community-based pro-
grams, since many studies use single-group designs or
small samples [15]. The effectiveness of these programs
is also uncertain in vulnerable groups such as older
adults with multimorbidity because they continue to be
underrepresented in diabetes research [11, 16, 17]. Fur-
ther, there has been little cost analysis in previous re-
search [11]. The difficulties in reaching, recruiting and
retaining this medically complex population have been
reported by others [18].
In summary, the effectiveness of self-management pro-
grams for older adults with T2DM and multimorbidity
is currently uncertain. More research is needed using
objective measures of self-management behaviours,
pragmatic designs to provide realistic estimates of treat-
ment effects, and robust cost analyses [11]. This paper
presents the results of a trial that addresses these current
gaps in the diabetes literature. It reports the results for
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the Alberta arm of a multisite pragmatic RCT examining
whether a 6-month self-management program for older
adults with T2DM and multimorbidity was more effect-
ive in improving health outcomes than usual care [19].
Results from the pilot study and Ontario arm of this trial
are reported elsewhere [20, 21].
Primary and secondary objectives
Primary Objective: To compare the effect of a 6-month
community-based intervention versus usual care on
physical functioning in older adults with type 2 diabetes
mellitus and 2 or more comorbidities.
Secondary Objective: To compare the effect of a 6-
month community-based intervention versus usual care
on mental health, depressive symptoms, anxiety, self-
efficacy, self-management, and healthcare costs in older
adults with type 2 diabetes mellitus and 2 or more
comorbidities.
Methods
A multi-site, pragmatic, randomized controlled trial was
conducted in Alberta, Canada. In accordance with the
Pragmatic Explanatory Continuum Indicator Summary-2
tool [22], this intervention used a pragmatic approach in
the recruitment of participants representative of the
population presenting in clinical practice and the flexible
delivery of the intervention by clinicians. The effective-
ness of a 6-month self-management program for
community-dwelling older adults with T2DM and MCC
was assessed in comparison to a control group receiving
usual care. Details of the study design and outcomes are
reported in the published study protocol [19].
Participants & recruitment
Participants were recruited from three Primary Care
Networks (PCNs) in the Edmonton, Alberta, Canada
census metropolitan area. PCNs are primary care clinics
comprised of family physicians, nurses, nurse practi-
tioners, dietitians, pharmacists, social workers and men-
tal health professionals. The three PCNs were selected
for this study because they were similar to one another
in terms of primary care services for people with dia-
betes, provider skills, and older adults served. Study re-
cruitment was conducted from September, 2015 to
October, 2016. Clients who had been enrolled at the
PCN within the past 24 months were screened (n = 725)
by employees of the PCNs for potential inclusion and
were eligible to participate if they were 65 years or older,
living in the community, able to speak English, diag-
nosed with T2DM by a physician, self-reported at least 2
other chronic conditions (see Supplemental File - Table
1 for full list of conditions), not planning to leave the
community during the 6-month study period, if they
passed a cognitive screening assessment (achieved at
least 5 correct responses on the Short Portable Mental
Status Questionnaire [23], and if they were referred to
or participated in a chronic disease management pro-
gram at the participating PCNs within the previous 24
months. Clients were excluded if they were living in a
long-term care facility or if someone in the same house-
hold was also enrolled in the study.
Randomization
Of the 608 eligible clients, 132 (22%) provided their writ-
ten consent and were enrolled in the study. The study
flow is outlined in Fig. 1. Reasons for exclusion from
study participation and for declining study participation
are reported in Fig. 1. Within each PCN, participants
were assigned to either the intervention or the usual care
group using permuted block randomization (random
block size sequences of 2, 4 and 6) administered by a
centralized web-based service (RedCap) independent of
the research term that allocated clients at each site to
the 2 groups in accordance with the sequence and using
a 1:1 ratio.
Intervention
The Aging, Community and Health Research Unit-
Community Partnership Program (ACHRU-CPP) was
delivered by an interprofessional team consisting of a
Registered Nurse (RN), Registered Dietitian (RD), and
Program Coordinator (PC). RNs and RDs were em-
ployees of the PCNs. PCs were employees of community
partner organizations where the monthly group sessions
were hosted. Community partner organizations were se-
lected based on pre-existing relationships with respective
PCNs. Below we provide a brief summary of the inter-
vention, and refer those seeking further information to
the prior publications [20, 21].
The six-month intervention was grounded in Ban-
dura’s Social Cognitive Theory [24], which recognizes
the central role of self-efficacy in achieving (self-manage-
ment) behavior change. The intervention was co-
developed with older adults, family caregivers, and com-
munity service providers (e.g., family physicians, RNs)
and designed using the guidelines for developing com-
plex interventions [25], best practice guidelines for dia-
betes [26], and empirical evidence on managing diabetes
in older adults, The intervention included several inter-
acting components: 1) up to three in-home visits by the
RN, RD or both; 2) six monthly group sessions at the
community site; 3) monthly intervention team case con-
ferences; and 4) care coordination led by the RN who
worked collaboratively with the other interventionists
and PCN providers (e.g., family physicians) and linked
the client to other relevant health or social services.
Family caregivers were invited to attend the in-home
visits and monthly group sessions, to recognize their key
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role in supporting the older adult participants. The
monthly group sessions included education offered by
the RN or RD, exercise led by the PC, a light meal, and
informal peer support (i.e., participants in the group ses-
sion supported one another by sharing experiences, chal-
lenges and strategies for managing diabetes within the
context of multimorbidity). Monthly case conferences
enhanced team collaboration and communication by
providing the provider team with regular opportunities
to share observations about participants strengths, chal-
lenges and goals related to managing diabetes and other
chronic conditions; identify needs related to other
community-based services; and prepare for upcoming
group sessions. The intervention was tailored to patient
needs and preferences and the local context. For ex-
ample, patients could decline any number of home visits
or group sessions, and all participants continued to have
access to the programs and services normally offered by
the PCN. At one of the PCNs, in order to be consistent
with usual care, the intervention team also included a
Pharmacist and Kinesiologist. In this PCN, the kinesiolo-
gist took on a similar role to the PC in the other sites.
Intervention training and fidelity
The following evidence-based strategies [27] were used
to monitor the intervention and enhance implementa-
tion fidelity:
1. Training/Educational Workshops: The Research
Coordinator led a training session for the providers
(i.e., RNs, RDs, PCs) before implementation of the
intervention at the study sites. Training at the sites
occurred over two-days. Each session was sup-
ported with role-appropriate training manuals. The
training focused on intervention components and
acceptable ways to tailor them, guidance on
interprofessional collaboration (including working
with family physicians and other care providers),
Fig. 1 Study Flow Diagram
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education and role-playing to develop skills in
motivational interviewing, promoting self-
management, best practices for the prevention and
management of multimorbidity, and caregiver
assessment and support strategies. Examples of
acceptable ways to tailor the intervention included
the number and approximate timing of in-home
visits and goals/activities/timeline outlined in the
client care plan,
2. Monthly Implementation Meetings: The Principal
Investigator (PI) and Research Coordinator
conducted monthly meetings with the providers to
discuss the progress of the study, provide feedback
and education, and discuss challenges and potential
solutions related to implementation of the
intervention. Through this strategy, the research
team supported the providers who were
implementing the intervention and gave them
protected time to reflect on the intervention, share
lessons learned, and support one another’s learning.
3. Reminders: The PI and Research Coordinator
provided regular updates on the study to the
providers, including successes and areas for
improvement related to the intervention.
4. Audit and feedback: The providers were asked to
keep logs of intervention-specific activities that were
carried out (i.e., home visits, case conferences). At
one-month intervals, the PI and Research
Coordinator conducted audits of the study-related
documentation to assess fidelity by reviewing the
extent to which the providers adhered to delivering
the components of the intervention. A
comprehensive audit and feedback system has been
shown to be effective when combined with
education, outreach visits, or reminders [28].
Outcomes & measures
Details regarding outcome measures are described in the
study protocol [19]. The primary study outcome was the
Physical Component Summary (PCS) score from the 12-
item Medical Outcomes Study Short Form-12v1 Health
Survey (SF-12) [29]. Secondary outcomes included the
Mental Component Summary (MCS) score of the SF-12
[29], depressive symptoms assessed by the Centre for
Epidemiological Studies Depression Scale (CESD-10)
[30], anxiety assessed by the Generalized Anxiety Dis-
order (GAD-7) scale [31], self-efficacy assessed by the
Self-Efficacy for Managing Chronic Disease scale [32],
and self-management activities assessed by the Summary
of Diabetes Self-Care Activities (SDSCA) scale [33].
Healthcare use was measured using the Health and Ser-
vices Utilization Inventory (HSSUI) [34–36]. The cost
analysis applied unit costs to the service volumes re-
ported in the HSSUI [37] and assumed a societal
perspective in order to inform the broad allocation of re-
sources in the public interest [38]. Outcome measures
were assessed at baseline and at the 6-months follow-up.
Guidelines are available for judging clinical signifi-
cance for only some study measures. SF-12 developers
suggest minimally important difference (MID) of 3 for
interpreting group mean summary score differences
(PCS, MCS) and warn against comparing subdomain
scores over time. The CESD-10, GAD-7, Self-Efficacy for
Managing Chronic Disease, and SDSCA do not have
established MIDs.
Blinding
In order to reduce bias, the statistician and research as-
sistants that collected the assessment data were blinded.
It was not feasible to blind participants or providers.
Sample size
Sample size was calculated based on the primary out-
come measure, the PCS from the SF-12. The target en-
rollment was 160 clients to account for an expected 20%
attrition and to ensure 80% power with medium effect
size (0.50), and (two-sided) alpha equal to 0.05.
Statistical analysis
The reporting of this trial follows the CONSORT guide-
line (www.consort-statement.org). We applied intention-
to-treat principle to analyze the data. Data are presented
as means and standard deviations for continuous vari-
ables and as numbers and percentages for categorical
variables. Analysis of covariance (ANCOVA) was used
to test the differences in study outcomes between the
intervention and usual care groups at 6 months. Separate
ANCOVA models were run for each outcome where the
6-month outcome was the dependent variable, the group
(intervention, usual care) was the independent variable,
and the baseline outcome value was the covariate. Confi-
dence intervals (95%) are reported for mean differences.
Multiple imputation (n = 132) was employed using the
procedure described by He [39]. A complete case ana-
lysis (n = 121), performed using only clients with
complete outcome data, was conducted as a sensitivity
analysis and the results are provided in Supplemental
File (Table 2).
Subgroup analyses were proposed for the case where
overall trial results achieved statistical significance, with
the purpose being to examine the consistency of the
treatment effect across subsets of participants. Subgroup
analyses would be supplemental to main trial findings
and restricted to consideration of the following five
baseline factors selected a priori: age, number of chronic
conditions, sex, self-efficacy, and diabetes duration. We
hypothesized that the intervention may be less effective
in participants that are older, female, or have more
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chronic conditions, lower self-efficacy, or have been liv-
ing longer with diabetes. No subgroup analyses were
proposed for the case where overall trial results did not
achieve statistical significance, because these are consid-
ered inappropriate by the scientific community [40–42].
The cost of health service use was compared between
the intervention and usual care groups. Clients reported
health service use at baseline for the six-month period
preceding study enrolment and immediately following
completion of the six-month intervention. The program
cost was estimated and added to total health service cost
for the intervention group and compared to the usual
care group. Program costs included the payment to pro-
viders to deliver the intervention (e.g., time spent in in-
home visits, group sessions, team conferences, travel).
Mann-Whitney U-test was employed to evaluate differ-
ences in median costs between the two groups due to
the positive skew of the data. All statistical analyses were
performed using SAS Version 9.4 (SAS Institute, Inc.,
Cary NC).
Ethics approval and consent to participate
This study was conducted in accordance with the Tri-
Council Policy Statement, Ethical Conduct for Research
Involving Humans [43]. Institutional ethics approval was
obtained from the Health Panel of the Health Research
Ethics Board at the University of Alberta (Pro00054028)
and renewed yearly as required. Operational approval to
conduct the research study was obtained from each
PCN. Written informed consent was obtained from all
participants.
Results
Study site characteristics
Table 1 provides information related to the characteris-
tics of the study sites. Sites 1 and 2 served suburban/
rural geographies. Half of the intervention teams at these
two sites, were Certified Diabetes Educators, and both
sites had PCs from a community partner organization to
run group sessions. Site 3 served an urban/metropolitan
geography, the intervention team included a Pharmacist
and Kinesiologist in addition to RN and RD; the inter-
ventionists at this site did not have the Certified Dia-
betes Educator credentials, and the kinesiologist was
replaced 3 months into the program.
Baseline characteristics of participants
In total, 22% (132/608) of eligible older adults consented
and entered the study (Fig. 1). Of the 132 enrolled par-
ticipants, 121 completed the 6-month study follow-up
(92%, 65 in the intervention and 56 in the control
group). Of the 11 participants that did not complete
study follow-up at 6 months (< 9% attrition), six partici-
pants could not be contacted.
Baseline characteristics of participants are reported in
Table 2. For both groups, more than 42% of participants
were 75 years and older and more than half were married
or living with a partner. Income differences were seen
across groups, with one-third of participants in the inter-
vention group reporting an annual income less than $40,
000 (CAD) compared to half of the participants in the
usual care group. Over 75% of both groups reported hav-
ing six or more chronic conditions (in addition to T2DM).
At least half of participants in both groups were diagnosed
with T2DM between 5 and 20 years ago, and approxi-
mately 30% were diagnosed with T2DM more than 20
years ago. There were a higher number of females allo-
cated to the intervention group (63%) than the usual care
group (45%). Group differences at baseline were also seen
for some outcomes, including higher scores for the inter-
vention group for MCS (55.6 versus 52.5) and self-
management (37.3 versus 34.2), and fewer depressive
symptoms in the intervention group (5.0 versus 6.7). It is
notable that the mean group difference for MCS exceeded
the MID (3.0), whereas the mean group difference in PCS
scores (0.70) was well below the MID. MIDs do not exist
for the other outcome measures; however, mean baseline
scores were similar across groups.
Intervention dose
Of the 70 participants in the intervention group, 68
(97%) received at least one home visit and 61 (87%)
Table 1 Study Site Characteristics
Characteristic Site 1 Site 2 Site 3
Geographic Density Suburban/rural Suburban/rural Urban/metropolitan
Clinics within PCN 13 11 35
Intervention Team 1 RN, 1 RD 2 RN, 2 RD 1 RN, 1 RD, 1 Pharmacist, 1 Kinesiologist
Program Coordinator (#) 1 1 0
Intervention Team turnover none none Kinesiologist replaced 3months into the program
Certified Diabetes Educator (#) 1 2 0
Community Partner Organization yes yes no
Participants Enrolled 24 47 61
PCN Primary Care Network, RD Registered Dietitian, RN Registered Nurse
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attended at least one group session. Participants had an
average of 1.8 (median = 2) out of a maximum of 3 home
visits and attended an average of 3.7 (median = 4) out of
a maximum 6 group sessions (data not shown).
Effects of the intervention
Pooled results from five imputations are presented in
Fig. 2. There was no significant difference between the
intervention and usual care groups for the primary
outcome, PCS (mean difference: -0.74; 95% CI: − 3.22 to
1.74). There were no significant differences between the
groups for MCS score (mean difference: 1.24; 95% CI: −
1.12 to 3.60), depressive symptoms (mean difference:
-0.25: 95% CI: − 2.03 to 1.53), anxiety (mean difference:
-0.93; 95% CI: − 2.63 to 0.77), or self-management (mean
difference: 0.79; 95% CI: − 2.37 to 3.96). Complete case
analyses were performed as a sensitivity analysis, and the
results are presented in Supplemental Table 1. The
Table 2 Baseline Characteristics of Older Adults with Type 2 Diabetes and Multiple Chronic Conditions (n = 132)a
Characteristic Intervention Group (n = 70) Usual Care Group (n = 62)
Femaleb, n (%) 44 (62.9) 28 (45.2)
Age in years, n (%)
65–69 19 (27.9) 19 (30.6)
70–74 19 (27.9) 17 (27.4)
75+ 30 (44.1) 26 (41.9)
Marital Status, n (%)
Married, living together 42 (60.9) 36 (58.1)
Never Married, Widowed, Divorced, Separated 27 (39.1) 26 (41.9)
Annual Income ($CAD), n (%)
$0 to $39,999 17 (33.3) 26 (50.0)
$40,000+ 34 (66.7) 26 (50.0)
Number of chronic conditions, n (%)
0–5 13 (18.6) 6 (9.7)
6–10 32 (45.7) 34 (54.8)
11–15 21 (30.0) 19 (30.6)
> 15 4 (5.7) 3 (4.8)
Number of prescription medications, n (%)
0–3 8 (11.4) 10 (16.1)
> 3 62 (88.6) 52 (83.9)
Time since diabetes diagnosis
0 to < 5 years 9 (13.6) 13 (21.0)
≥ 5 and < 20 years 37 (56.1) 32 (51.6)
≥ 20 years 20 (30.3) 17 (27.4)
Self-Efficacyc, mean (SD) 8.0 (1.6) 7.9 (1.5)
HRQoL - Physical Functioningd, mean (SD) 42.4 (10.5) 43.1 (11.7)
HRQoL - Mental Functioningb,e, mean & SD 55.6 (7.7) 52.5 (9.3)
Depressive Symptomsf, mean (SD) 5.0 (5.2) 6.7 (5.6)
Anxietyg, mean (SD) 2.9 (3.9) 2.9 (3.8)
Self-Managementh, mean (SD) 37.3 (11.7) 34.2 (9.3)
HRQoL health-related quality of life, SD standard deviation
aDifferences between the groups were tested using the chi-square test for categorical variables or the t-test for continuous normally-distributed variables
bp < 0.05, Randomization resulted in allocation of more females to ACHRU-CPP than intervention group
cMeasured by Self Efficacy for Managing Chronic Disease 6-item Scale, scale range 0–10
dMeasured by Physical Component Summary Score (PCS) of SF-12 survey, scale range 0–100
eMeasured by Mental Component Summary Score (MCS) of SF-12 survey, scale range 0–100
fMeasured by Center for Epidemiologic Studies Depression 10-Item Scale (CES-D-10), scale range 0–30
gMeasured by Generalized Anxiety Disorder 7-Item Scale (GAD-7), scale range 0–21
hMeasured by Summary of Diabetes Self-Care Activities Scale (SDSCA), scale range 0–63. SDSCA normally consists of 11 items (2 general diet, 3 special diet, 2
exercise, 2 blood glucose monitoring, 2 ft care). Two blood glucose monitoring items were excluded from the scale score because 45 (34%) of study participants
indicated that they did not have a monitoring plan
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complete case findings are in agreement with the mul-
tiple imputation analysis for the primary and secondary
outcomes (see Supplemental Table 1). Subgroup ana-
lyses were not done since statistical significance was not
achieved (see Statistical Analysis above).
Given the relatively high MCS scores at baseline ob-
served in the intervention group, we conducted an ex-
ploratory stratified analysis comparing the mean
differences in the groups for different MCS baseline
values. This analysis was done to see if improvements in
Fig. 2 Group Differences in Outcomes (Multiple Imputation, n = 132, 5 imputations)
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MCS were higher among those with lower baseline MCS
scores (defined as ≤50). This was indeed the case – i.e.,
the mean difference and 95% CI for those with a baseline
MCS score of 50 or less compared to those with more
than 50 was 2.85 (− 3.42 to 9.12) versus 0.42 (− 2.05 to
2.91). This analysis is supplemental and exploratory, and
therefore should be interpreted with caution; however, it
suggests that larger variation occurs in participants with
lower baseline scores, with the potential for significant dif-
ferences favouring the intervention (e.g., 9.12 upper CI
limit which is more than 3 times the MID).
Health service use costs
A comparison of health service use costs for the intervention
and control groups is presented in Table 3. For all but dia-
betes care services, the cost analysis showed no significant
differences in baseline to 6-month cost change between the
two groups. As expected, the significant difference in dia-
betes care cost change between the groups was due to the in-
clusion of intervention program costs in the intervention
group. However, this significant difference in diabetes care
cost change did not result in a group difference in total
health service costs (including or excluding acute care costs).
Discussion
This was a six-month intervention to test the effects of a
community-based program for older adults with T2DM and
multimorbidity on physical and mental functioning, self-
efficacy, depressive symptoms, anxiety, self-management
and service use costs. Although the overall benefits of the
intervention were inconclusive for physical and mental
functioning, the program shows the potential for significant
improvements in mental functioning in participants with
lower baseline scores and the program was shown to be cost
neutral relative to usual care.
The feasibility, acceptability, and benefits of the pro-
gram were demonstrated previously in a feasibility study
in Ontario [20]. Further, this pragmatic intervention was
also conducted in older adults with multimorbidity from
Diabetes Education Centres in Ontario, Canada [21]. In
Ontario, the intervention improved MCS score, SDSCA,
and depressive symptoms [21]. Additionally, certain
components of the intervention tested in our studies
have been shown to be effective in others. For example,
a study with exercise-based intervention showed im-
provement in body weight, blood pressure and several
quality of life measures in older adults with T2DM [44].
This study differed from the present study in that the
program was more focused on physical exercise, more
intense (three times per week versus monthly) and the
intervention lasted much longer (2 years). Another
exercise-based study in older adults with T2DM involv-
ing walking, resistance training, and flexibility exercises
showed an improvement in cognitive function testing
after 2 years [45]. Participants in the present interven-
tion in Alberta and Ontario were provided with exercise
resources and were encouraged to track their activity on
calendars provided to them by the intervention team.
Activity monitoring was not conducted in this study, but
represents a potential outcome of interest in future trials
testing the effectiveness of community-based interven-
tions in older adults with T2DM and MCC.
Table 3 Health and Social Service Cost Comparison of Intervention and Control Groups (n = 121 complete case analysis)
Service Intervention Usual Care Group
Differencea
Baseline Median
(Q1 to Q3)
6 Month Median (Q1
to Q3)
Baseline Median
(Q1 to Q3)
6 Month Median
(Q1 to Q3)
z
stat
p
value
Family Physician Visits $370.00 ($0.00 to $740.00) $555.00 ($0.00 to $925.00) $370.00 ($0.00 to $761.74) 555.00 ($185.00 to $740.00) 0.39 0.70
Physician Specialist $66.34 ($0.00 to $132.68) $74.09 ($0.00 to $181.85) $62.78 ($0.00 to $137.94) $47.68 ($0.00 to 149.52) −0.85 0.40
Acute Careb $0.00 ($0.00 to $510.30) $0.00 ($0.00 to $0.00) $0.00 ($0.00 to $0.00) $0.00 ($0.00 to $510.30) 0.84 0.40
Home Care $0.00 ($0.00 to $0.00) $0.00 ($0.00 to $0.00) $0.00 ($0.00 to $0.00) $0.00 ($0.00 to $0.00) 1.97 0.05
Diabetes Carec $0.00 ($0.00 to $57.43) $362.20 ($0.00 to $495.74) $0.00 ($0.00 to $60.00) $0.00 ($0.00 to $88.48) −5.57 < 0.001
Diagnostic Tests $176.19 ($0.00 to $311.07) $165.88 ($0.00 to 293.46) $125.05 ($0.00 to $306.92) $138.77 ($0.00 to $288.19) −0.22 0.82
Other Health
Professionalsd
$149.94 ($0.00 to $378.52) $29.30 ($0.00 to $161.25) $106.71 ($0.00 to $414.43) $0.00 ($0.00 to $83.60) −0.26 0.80
Prescription Medications $870.19 ($65.71 to $1570.69) $882.54 ($41.56 to $1446.05) $984.92 ($0.00 to 1594.31) $857.93 ($58.88 to
$1362.68)
−0.68 0.50
Total Costs (including
Acute Care)
$2419.49 ($220.35 to
$4480.67)
$2528.01 ($678.25 to
$3769.45)
$2283.63 ($103.93 to
$4002.23)
$2084.60 ($465.32 to
$3865.82)
−0.44 0.66
Total Costs (excluding
Acute Care)
$2168.27 ($220.35 to
$3345.99)
$2442.51 ($678.25 to
$3360.00)
$2100.65 ($103.93 to
$3006.94)
$1787.83 ($465.32 to
$3246.22)
−1.24 0.22
aWilcoxon Rank Sum test used to determine significance of group differences. P values are 2-sided
bIncludes 911 calls, ambulance, emergency department, hospitalization
cIncludes program costs for the intervention group (training, in-home visits, group sessions, case conferences). Difference between intervention and control group
favors control group
dIncludes provider of private services (e.g., pharmacist, dietitian, social worker, chiropodist, health care aide, physiotherapist, occupational therapist, homemaking
service) and alternative therapies (e.g., naturopath, chiropractor, reflexologist)
Miklavcic et al. BMC Geriatrics          (2020) 20:174 Page 9 of 14
Despite randomization, mean baseline MCS scores in the
intervention group were more than three points higher
(MID = 3.0) [46] than the usual care group (Table 3). This
may be helpful in understanding the inconclusive findings
of this study. Exploratory analysis suggests that the mean
difference in MCS score change (favoring the intervention)
was higher for those having lower baseline MCS scores
(scores ≤50). Further research is needed to replicate and
confirm this exploratory finding.
We also explored contextual factors that may have con-
tributed to the inconclusive findings of this trial. It is pos-
sible that in the current study, the quality of usual care for
persons with diabetes was already good; this would be
consistent with a recent study of a lifestyle intervention
for persons with T2DM conducted at four PCNs in Al-
berta [47]. In the current study, there were also a number
of changes in the staff and managers of the PCNs, which
may have impacted the adoption of the intervention and
thus the results; this instability of managers was also noted
as an important contextual factor in two quality improve-
ment intervention studies with persons with T2DM con-
ducted with PCNs in Alberta [48]. The background and
experience of providers in diabetes care also differed
among the sites, which may have impacted the findings.
The intervention arm of the current study included the
intervention in addition to usual care. Usual care may have
differed slightly across the PCNs, but we are not aware of
large differences across the sites. The original protocol for
the study included only an RN and RD as the intervention
teams. In establishing implementation across study sites, it
was deemed that a Pharmacist and Kinesiologist should be
included in the usual or standard of care for older adults
with T2DM and MCC at one of the PCNs. Accordingly,
and in keeping with the principles of the pragmatic trial, a
Pharmacist and Kinesiologist were included on the inter-
vention team for this study site (Table 1). As almost half of
participants were recruited from this particular study site,
higher baseline health measures discussed previously
(MCS) or improved T2DM self-management may have re-
duced the comparative benefits of the intervention. It is also
possible that the chronic disease management services of-
fered by PCNs as part of usual care contributed to the lack
of statistically significant findings. Further research is
needed to better understand the influence of these context-
ual factors on study outcomes.
A recent systematic review of RCTs reporting non-
significant results emphasized the importance of interpret-
ing confidence intervals in order to distinguish “negative”
findings from “inconclusive” ones [49]. The authors point
out that the p-value alone does not allow readers of an
RCT to distinguish whether: 1) the treatment does not
have a clinically meaningful impact, and 2) the study is
unable to rule out a clinically meaningful treatment effect,
resulting in “inconclusive” findings. The authors
recommend examining confidence limits in relation to the
MID (not simply in relation to the 0 or 1 threshold ac-
companying the effect measure). We can apply this rec-
ommendation to our outcome data for which MIDs are
available (PCS, MCS). Figure 3 provides a graphic illustra-
tion of the interpretation of the MCS and PCS findings for
the primary analysis. For MCS, the findings would be con-
sidered inconclusive in terms of the superiority of the
intervention but rule out the superiority of the control be-
cause the upper 95% control limit is above the MID but
the lower limit does not extend to the MID favouring the
control. For PCS, the findings would be considered incon-
clusive in terms of the superiority of the usual care group
but rule out the superiority of the intervention because
the lower limit extends beyond the MID favouring the
control but the upper limit does not extend past the MID
favouring the intervention [49].
We should also acknowledge the recruitment challenge
encountered in this study. Only 22% of eligible partici-
pants agreed to participate in the study. This low uptake is
disappointing, but is not uncommon and has been cited
by other studies of older adults with multimorbidity, such
as the 3D trial [50] where 33% of eligible participants
agreed to participate and the Guided Care cluster trial
[51] where 38% agreed to participate. Recruitment chal-
lenges appear to be a significant and realistic barrier to
studying vulnerable older adult populations, and effective
solutions to the recruitment/retention challenges remain
elusive and a priority for future research.
Finally, we acknowledge the role of HbA1C as an im-
portant outcome to obtain in future trials testing dia-
betes interventions. While our study did not have access
to HbA1C measures, we recognize it as a key indicator
of diabetes and a potential motivator for both physicians
and patients. However, including it as an outcome intro-
duces significant interpretive challenges as well, due to
the biologic and patient-specific factors common in
older adults that can render HbA1C measures mislead-
ing/inaccurate (e.g., comorbid conditions, acute illness
episodes, hospitalizations). It is therefore critical to apply
an individualized patient lens to HbA1C measures and
changes over time, when judging the effectiveness of in-
terventions [52, 53].
Strengths, limitations and areas for future research
This study employed a rigorous pragmatic design.
Personnel employed by the site and external to the re-
search team delivered the program. Intervention fidelity
was enhanced by multiple approaches, including stan-
dardized provider training., and regular meetings were
held with the research team. The pragmatic design cap-
tured clients from a population typically seen in a clinic
setting for chronic disease management. Utility of a RD
in the ACHRU-CPP intervention allowed for a holistic
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approach to dietary counselling that extends beyond cal-
orie restriction to goal setting, general healthy eating,
and food preparation. This is particularly important in
strategies for older adults as considerations for body
mass distribution (lean tissue vs. visceral adiposity) may
be more important than targeted weight loss alone [54].
Additionally, the inclusion of a RD in the intervention
team is a strength as intensive dietary support is recom-
mended for older adults, men, and individuals whom
have been living with T2DM for a long time [55].
Study limitations include the use of self-reported data
and the unavailability of clinical outcome data (e.g.,
HbA1c). However, concerns have been expressed regard-
ing the relevance of clinical outcomes [56], recent work
on patient-reported outcomes (PROMs) is motivated by
these concerns [see http://www.healthmeasures.net/ex-
plore-measurement-systems/promis/intro-to-promis],
and PROMs such as the PCS used in this study are in-
creasingly used as primary outcomes in interventions for
older adults with multimorbidity [50, 51]. We were un-
able to obtain the target sample (enrolled 132, needed
160), which could have led to the study’s non-significant
findings. With the exception of outcomes from the SF-
12 survey (PCS, MCS), MIDs have not been established
for the other outcomes included in this study. Thus, dis-
tinguishing “negative” effects from “inconclusive” ones
by comparing the 95% CI to MIDs could not be done
for outcomes other than PCS & MCS, thereby limiting
our understanding of the impact of the intervention.
This advanced interpretation of CIs in clinical trials is
particularly important because it ensures that potentially
beneficial interventions are not prematurely abandoned
[49]. Interpretation of subscales/subdomains can also be
limited. For example, although there was improvement
in the Specific Diet subscale score (see Supplemental
Table 1, complete case analysis), Toobert and Johnson
caution against over-interpretation because this subscale
suffers from poor consistency and low internal reliability
[33]. The duration of the intervention and the length of
follow-up may have been insufficient to see improve-
ments to physical health, and/or it may be that improve-
ments to mental functioning/health are needed before
improvements in physical health can be seen. Strong
cross-effects between mental and physical health have
been reported; however little is known about the poten-
tial pathways through which mental health affects phys-
ical health and vice versa [57] Subgroup analyses were
not performed due to the overall non-significant find-
ings, but as a result we cannot assess the potential im-
pact of differences such as a gender imbalance among
the groups or differences across sites. We did not have
access to information on important covariates such as
physical activity and nutritional intake, which may have
influenced the study outcomes.
This study also suggests potential areas to pursue in
future research studies. Some studies that have focused
on physical exercise have been effective, thus exploring
the impact of physical activity components that vary in
type or intensity within our intervention may be benefi-
cial. Similar comments apply to other components of
our intervention (e.g., diet, social participation), since
our intervention is complex making it challenging and
potentially inappropriate to isolate the effectiveness of
individual elements [25]. Inclusion of clinical outcome
measures such as HbA1C could also help in understand-
ing effects, providing careful attention is given to the
levels/changes appropriate and safe for individual older
adults enrolled in the study.
Conclusions
This pragmatic trial of an interprofessional, intersectoral
self-management intervention for older adults with
T2DM and multimorbidity conducted in primary care
networks in Alberta demonstrated inconclusive results
Fig. 3 Interpreting 95% Confidence Intervals for PCS and MCS (“Inconclusive” Findings). Note: MID: minimally important difference
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for physical and mental functioning (PCS and MCS of
the SF-12). It is possible that contextual factors may
have contributed to these inconclusive results, such as
an already good quality of chronic disease management
services in PCNs. Further, it is possible that baseline dif-
ferences between groups may have played a role in the
results obtained. Further research on the impact of this
intervention and the factors that contribute to the re-
sults seen is recommended.
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